TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.87M | 20.69M | 20.20M | 18.52M | 17.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.87M | 20.69M | 20.20M | 18.52M | 17.65M |
| Cost of Revenue | 7.02M | 6.63M | 6.00M | 5.91M | 6.33M |
| Gross Profit | 13.85M | 14.06M | 14.20M | 12.61M | 11.32M |
| SG&A Expenses | 18.27M | 19.18M | 20.98M | 20.44M | 17.55M |
| Depreciation & Amortization | 95.00K | 95.00K | 95.00K | 95.00K | 95.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.52M | 28.24M | 29.28M | 28.99M | 26.00M |
| Operating Income | -6.65M | -7.55M | -9.08M | -10.47M | -8.35M |
| Income Before Tax | -8.90M | -8.60M | -9.89M | -11.21M | -9.35M |
| Income Tax Expenses | 145.00K | -- | 33.00K | 52.00K | -144.00K |
| Earnings from Continuing Operations | -9.04M | -8.60M | -9.92M | -11.26M | -9.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.04M | -8.60M | -9.92M | -11.26M | -9.21M |
| EBIT | -6.65M | -7.55M | -9.08M | -10.47M | -8.35M |
| EBITDA | -6.42M | -7.31M | -8.81M | -10.21M | -8.09M |
| EPS Basic | -0.17 | -0.19 | -0.22 | -0.25 | -0.23 |
| Normalized Basic EPS | -0.10 | -0.12 | -0.14 | -0.15 | -0.15 |
| EPS Diluted | -0.17 | -0.19 | -0.22 | -0.25 | -0.23 |
| Normalized Diluted EPS | -0.10 | -0.12 | -0.14 | -0.15 | -0.15 |
| Average Basic Shares Outstanding | 51.68M | 45.42M | 45.37M | 45.27M | 40.07M |
| Average Diluted Shares Outstanding | 51.68M | 45.42M | 45.37M | 45.27M | 40.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |